As of 05 Nov 2026 03:31 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/043 (07 Sep 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Ramipril 1.25mg, 2.5mg, 5mg and 10mg capsulesaffected product · inferred from phrasing | Limited supply, as stated | the end of October 2026precision: a month · window end 31 Oct 2026, derived from “the end of October 2026” | notice of 07 Sep 2026 |
| Ramipril 1.25mg, 2.5mg, 5mg and 10mg tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 07 Sep 2026 |
| Alternative ACE inhibitors and ARBsclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 07 Sep 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register — 2 earlier protocols on this record have expired: SSP087 (to 30 Oct 2026), SSP071 (to 29 Nov 2024). Matching is by name until identifier coding lands.
Named in the source as remaining available
- Ramipril 1.25mg, 2.5mg, 5mg and 10mg tablets — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Ramipril
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 3 times on record since 2024 — a recurring shortage spanning 2.1 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 07 Sep 2026 | Medicine Supply Notification: Ramipril 1.25mg, 2.5mg, 5mg and 10mg capsules | Supply notification | Tier 2 | MSN/2026/043 |
| 23 Apr 2026 | Medicine Supply Notification: Ramipril 1.25mg capsules | Supply notification | Tier 2 | MSN/2026/022 |
| 06 Aug 2024 | Medicine Supply Notification: Ramipril 2.5mg tablets | Supply notification | Tier 2 | MSN/2024/082 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2026)33 Ramipril 1.25mg, 2.5mg, 5mg and 10mg capsules · issued 09 Sep 2026 · valid until end of October 2026, as stated · matched by name PDF ↗
- MSAN(2026)15 Ramipril 1.25mg capsules · issued 27 Apr 2026 · valid until end of May 2026, as stated · matched by name PDF ↗
- MSAN(2024)46 Ramipril 2.5mg tablets · issued 09 Aug 2024 · valid until November 2024, as stated · matched by name PDF ↗